Goodwin and KPMG hosted their 4th Annual Symposium held during the 41st Annual JP Morgan Healthcare Conference week.
Life sciences companies have many opportunities to thrive in the face of changing tides. At this year's symposium in January, we delved into strategies that enable life sciences companies to enhance research and development; optimize value from licensing, M&A, and other transactions; and secure capital for growth. By embracing these opportunities, life sciences companies can not only avoid getting caught in a riptide but chart new paths to success. If you missed our Symposium in person, please check the video recordings of each panel.
2023 Agenda & Videos
Deepa Rich (moderator) — Partner, Goodwin
David Schaffer — Professor at UC Berkeley and Director of QB3
John Boyce — Co-Founder and Managing Director, Tiger Gene Ventures
Galya Blachman — General Counsel, Chief Compliance Officer and COO, 4:59 Initiative at 5AM Ventures
Sally Wang Liang — JD, MPH, Venture Partner, Viva Bioinnovator
Kristin Ciriello Pothier (moderator) — Global and US Leader, HCLS Deal Advisory and Strategy, KPMG
Hon’ble Minister Mr. K.T. Rama Rao, Hyderabad
Marc Stapley — CEO, Vercyte
Nicole Lambert — Chief Operating Officer, Myriad Genetics
Gitte Pedersen — CEO, Genomic Expression
Gabriele Allegri — Global Commercial Head, Precision Medicine, Janssen Pharmaceutical Companies of Johnson & Johnson
Lily Wound (moderator) — Partner, Goodwin
Lynn Durham — Stalicla
Martin Akerman — Co-Founder and CTO, Envisagenics
Carolina Aguilar — CEO and Co-Founder, INBRAIN
Michael McInerney — Head of Digital Health Business Development, Bristol Myers Squibb
Janet Lehman (moderator) — Audit Partner, National VC Life Sciences Leader, KPMG
Ben Marsh — Partner, Goodwin
Sean MacGregor — Executive Director, Healthcare Investment, JP Morgan
Marc Dumaine — AAS Partner, KPMG
Jennifer (Scutt) Ziolkowski — Chief Financial Officer at Vigil Neuroscience
Shari Mager (moderator) — Partner and US Deal Advisory & Strategy National Capital Markets Readiness Leader
Marianne Sarrazin — Partner, Goodwin
Rakhee Bhagat — Managing Director and Partner, Healthcare, William Blair
Peter Garcia — CFO, ALX Oncology
Dive Deeper With Goodwin
Goodwin's Life Sciences Practice
Our Life Sciences practice is uniquely positioned to partner with innovators and investors operating in a fast-moving, technology-driven environment. We work with life sciences companies throughout the corporate lifecycle, as well as with investors, banks, and others in the life sciences ecosystem.
Life Sciences Perspectives
Our Life Sciences Perspectives blog is a resource specifically aimed at addressing your most frequent and pressing issues in this dynamic industry. We provide the insights you need most, including developments on private and public company matters, licensing deals and collaborations, patent and IP matters, FDA and healthcare regulatory compliance, and European and Asian developments for life sciences companies.